Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) hit a new 52-week low during trading on Tuesday . The stock traded as low as $14.08 and last traded at $14.75, with a volume of 592434 shares trading hands. The stock had previously closed at $15.67.
Analyst Ratings Changes
KMTS has been the subject of several recent research reports. Wolfe Research initiated coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "outperform" rating and a $29.00 price target for the company. The Goldman Sachs Group reduced their price target on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a research report on Wednesday, April 16th. Bank of America started coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "buy" rating and a $30.00 price objective on the stock. Piper Sandler started coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued an "overweight" rating and a $27.00 price objective on the stock. Finally, Stifel Nicolaus started coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "buy" rating and a $28.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $27.50.
Read Our Latest Report on Kestra Medical Technologies
Kestra Medical Technologies Stock Up 7.0%
The stock's 50 day moving average is $20.21.
Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last announced its earnings results on Monday, April 14th. The company reported ($1.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.61). During the same period in the prior year, the company posted ($1.18) earnings per share.
Hedge Funds Weigh In On Kestra Medical Technologies
A number of hedge funds have recently added to or reduced their stakes in KMTS. Brown Advisory Inc. bought a new position in Kestra Medical Technologies during the 1st quarter worth $13,716,000. Caas Capital Management LP acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $1,470,000. Jennison Associates LLC acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $1,869,000. TD Asset Management Inc acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $2,306,000. Finally, Federated Hermes Inc. acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $9,968,000.
Kestra Medical Technologies Company Profile
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Featured Articles
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
